US 11040959
Diprovocims: a new and potent class of TLR agonists
granted A61PA61P37/04
Quick answer
US patent 11040959 (Diprovocims: a new and potent class of TLR agonists) held by The Board of Regents of the University of Texas System expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P37/04